查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1803509

非微生物生物刺激素市場按產品類型、產地、作物類型、形態、應用方法、最終用戶和分銷管道分類 - 全球預測，2025-2030 年

Non-microbial Biostimulants Market by Product Type, Source, Crop Type, Form, Application Method, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

非微生物生物刺激素市場預計在 2024 年達到 17.5 億美元，在 2025 年成長至 19.8 億美元，在 2030 年達到 37.2 億美元，複合年成長率為 13.33%。

主要市場統計數據
基準年2024年 17.5億美元
預計2025年 19.8億美元
預測年份 2030 37.2億美元
複合年成長率（%） 13.33%

全面介紹非微生物生物刺激素及其在促進現代農業系統永續作物生產中的作用

隨著種植者、配方師和經銷商尋求能夠提高作物抗逆性、養分利用效率和植物整體性能的工具，而非僅僅依賴傳統農藥，非微生物生物刺激素領域正受到越來越多的關注。萃取、分餾和製劑科學領域的創新正在拓寬農學家可用的活性成分範圍，而不斷發展的農藝實踐和永續性重點也正在推動其在各種種植系統中的應用。同時，供應鏈動態和監管壓力正在重塑相關人員採購投入和設計應用方案的方式。

科學檢驗、買家成熟度與通路創新如何融合，重新定義整個生物刺激素領域的競爭優勢

由於監管環境、種植者期望和技術能力的變化，非微生物生物刺激素正從一種小眾補充劑演變為作物綜合管理的核心組成部分。近幾季，其功效宣傳受到越來越嚴格的審查，促使供應商透過可重複的田間試驗和更先進的分析表徵來證實其功效。這種對證據的重視增強了產品的差異化，那些展現出持續生理功效的產品獲得了優先的試驗和分銷支持。

近期關稅對美國採購、配方策略和供應鏈彈性的業務和商業影響

美國近期的關稅措施導致非微生物生物刺激素供應鏈的複雜程度不斷提升，影響了原料採購、配方成本和物流規劃。由於許多活性成分和原料來自全球各地的供應商，尤其是在擁有專業提取能力的地區，進口關稅的變化迫使配方師重新評估籌資策略。這種重新評估可能包括：將某些原料近岸外包，尋找擁有重疊化學品的合格替代供應商，以及增加緩衝庫存以對沖波動性。

精準細分洞察揭示產品類型、產地、作物類型、形式、應用和通路如何決定技術優先順序和商業性成功

細分分析揭示了產品結構、來源特徵、作物最終用途、物理形態、應用形式、最終用戶概況和通路動態如何影響產品開發優先順序和商業策略。在考慮產品類型時，包括胺基酸和胜肽、腐殖質、植物抽取物、蛋白質水解物和海藻萃取物在內的產品組合必須平衡功效、一致性和成本。在胺基酸和胜肽中，螯合氨基溶液和胜肽提供不同的功能特性；富裡酸和腐殖酸鉀在腐殖質中提供差異化的途徑；植物抽取物和植物激素萃取物在植物抽取物中提供不同的作用方式。無機來源和有機來源的選擇會影響配方選擇、監管途徑和種植者偏好，進而影響作物產品定位。

採用模式和營運考量需要協調美洲、歐洲、中東和非洲地區以及亞太地區的產品、監管和通路策略

各地區在應用促進因素和商業動態的差異凸顯了美洲、歐洲、中東和非洲以及亞太地區制定客製化策略的必要性。在美洲，種植者通常優先考慮能夠與大規模機械化作業無縫銜接，並能顯著提高養分效率和緩解壓力的解決方案。分銷網路正在多元化，涵蓋強大的批發和零售管道，數位化採購正在加速商業農產品對數位化的採用。該地區也體現出一種現實的結合：高價值園藝作物的早期採用，以及對具有明顯農藝效益回報的大面積作物日益成長的興趣。

產業領導者的策略劇本強調證據、供應鏈彈性、數位化支持和夥伴關係主導的商業規模

非微生物生物刺激素領域的主要企業正聚焦於幾項策略重點，這些重點使高績效企業在眾多競爭對手中脫穎而出。其中最主要的是投資於獲取強而有力的證據，利用綜合測試網路和獨立檢驗研究來證明在代表性農藝條件下的生理功效。此類科學投資，加上清晰的農藝指導和教育計劃，增強了經銷商和種植者對產品性能的信心。

企業現在可以採取切實可行的措施來增強供應彈性、檢驗跨地域績效並最佳化產品組合和通路經濟效益

行業領導者可以立即採取措施，將技術投資與商業性執行和營運韌性相結合，從而鞏固其市場地位。優先開展跨地區、作物類型的嚴格田間檢驗項目，以建立堅實的依證，支持差異化宣傳，並為農藝指導提供參考。在驗證的同時，重新評估您的供應鏈，並專注於供應商多元化、品質保證控制和合約條款，以降低貿易政策波動帶來的機會。這種雙重關注既能保護產品完整性，又能支援靈活的籌資策略。

綜合混合方法研究途徑，結合初步測試、相關人員訪談、技術文件審查和供應鏈檢驗，以獲得可行的見解

本研究整合了主要農藝試驗數據、供應商和經銷商訪談、產品技術文件以及專注於製劑科學和貿易動態的二手文獻。主要研究包括與農藝師、製劑化學家、採購主管和通路合作夥伴進行結構化討論，以了解業務現狀以及對近期政策變化的策略回應。試驗評估強調在代表性環境條件下進行重複試驗，並包括定性農藝觀察和定量生理指標（如有）。

策略要務整合，將科學檢驗、採購敏捷性和客製化商業模式與持久的競爭成果結合

最後，非微生物生物刺激素領域正處於技術創新和商業性成熟的十字路口。隨著循證檢驗成為市場准入的必要條件，那些投資於嚴格測試、靈活採購和針對特定管道的價值提案的公司將有望獲得競爭優勢。貿易政策的發展和區域結構差異將要求企業制定適應性策略，將採購彈性與有針對性的產品設計相結合。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 奈米膠囊腐植酸和富裡酸配方的開發，用於作物測試中的控制釋放
  • 增加海藻萃取物與微量營養素的結合使用，以提高作物的抗旱能力
  • 引入基於無人機和無人駕駛飛機的葉面噴布系統，以實現精準的非微生物生物促效劑施用
  • 美國和歐盟加強監管協調，簡化植物來源生物刺激素註冊流程
  • 將非微生物生物促效劑整合到種子披衣中可促進根系早期發育和均勻出苗
  • 利用高通量表現型分析量化非生物脅迫條件下生物刺激素治療的功效

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 非微生物生物刺激素市場（依產品類型）

  • 胺基酸和胜肽
    • 螯合氨基溶液
    • 胜肽
  • 腐植質
    • 富裡酸
    • 腐植酸鉀
  • 植物萃取物
    • 植物萃取物
    • 植物激素萃取物
  • 蛋白質水解物
  • 海藻萃取物

9. 非微生物生物刺激素市場（依來源）

  • 無機
  • 有機的

10. 非微生物生物刺激素市場（依作物類型）

  • 田間作物
    • 糧食
    • 油籽
    • 豆子
  • 水果和蔬菜
    • 莓果
    • 萵苣
    • 番茄
  • 觀賞植物
    • 芙蓉
    • 蘭花
    • 玫瑰
    • 鬱金香
  • 草地
    • 狗狗牙根草
    • 肯塔基藍草

11. 非微生物生物刺激素市場（依形態）

  • 液體
    • 集中
    • RTU
  • 粉末
    • 顆粒狀
    • 可溶性粉劑

12. 非微生物生物刺激素市場（依應用）

  • 葉面噴布
    • 無人機應用
    • 手動應用
  • 種子處理
    • 塗層
    • 啟動
  • 土壤處理
    • 滴灌
    • 施肥灌溉

13. 非微生物生物刺激素市場（依最終用戶）

  • 商業用戶
  • 個人用戶

14. 非微生物生物刺激素市場（按分銷管道）

  • 離線
  • 線上
    • 公司網站
    • 第三方市場

15. 美洲非微生物生物刺激素市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16. 歐洲、中東和非洲非微生物生物刺激素市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

17. 亞太地區非微生物生物刺激素市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第18章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • BASF SE
    • Syngenta AG
    • Agricen
    • Agrinos Inc.
    • AgroLiquid
    • Arysta LifeScience Corporation
    • Bio Huma Netics, Inc.
    • Bioiberica SA
    • Biolchim SpA
    • Biostadt India Limited
    • Corteva, Inc.
    • FMC Corporation
    • Haifa Group
    • Helena Agri-Enterprises LLC
    • Hello Nature Worldwide
    • Isagro SpA
    • Koppert Biological Systems
    • L.Gobbi Srl
    • Lallemand Inc.
    • Novozymes A/S
    • Rovensa Next
    • Seipasa
    • UPL Limited

第19章 研究人工智慧

第20章 研究統計

第21章 研究聯絡人

第22章 研究報導

第23章 附錄

Product Code: MRR-F14BA1B34144

The Non-microbial Biostimulants Market was valued at USD 1.75 billion in 2024 and is projected to grow to USD 1.98 billion in 2025, with a CAGR of 13.33%, reaching USD 3.72 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.75 billion
Estimated Year [2025] USD 1.98 billion
Forecast Year [2030] USD 3.72 billion
CAGR (%) 13.33%

A comprehensive orientation to non-microbial biostimulants and their role in advancing sustainable crop performance across modern agricultural systems

The non-microbial biostimulants sector is undergoing a period of heightened attention as growers, formulators, and distributors seek tools that improve crop resilience, nutrient use efficiency, and overall plant performance without relying solely on traditional agrochemicals. Innovations in extraction, fractionation, and formulation science have broadened the suite of active ingredients available to agronomists, while evolving agronomic practices and sustainability priorities have increased adoption across diverse cropping systems. Concurrently, supply chain dynamics and regulatory pressures are reshaping how stakeholders source inputs and design application programs.

This introduction positions the reader to understand the interplay between product innovation, channel transformation, and regulatory developments. It highlights the importance of integrating technical efficacy with commercial viability, and it frames subsequent sections that explore structural shifts, tariff impacts, segmentation-derived insights, regional differentiators, corporate strategies, and practical recommendations. By focusing on the intersection of science, supply chains, and grower economics, the study equips stakeholders to make informed choices about product portfolios, partnerships, and go-to-market models.

How scientific validation, buyer sophistication, and channel innovation are converging to redefine competitive advantage across the biostimulant landscape

The landscape of non-microbial biostimulants is shifting from a niche adjunct to a core component of integrated crop management, driven by changes in regulatory frameworks, grower expectations, and technological capability. Over recent seasons, performance claims have been scrutinized more rigorously, prompting suppliers to substantiate benefits through replicated field trials and enhanced analytical characterization. This emphasis on evidence has elevated product differentiation, with those that demonstrate consistent physiological benefits winning preferential trial placements and distribution support.

Simultaneously, buyer behavior is evolving. Commercial users and individual growers increasingly demand ease of use, compatibility with existing nutrient programs, and transparent sourcing. This demand has incentivized suppliers to prioritize formulation stability, label clarity, and application flexibility, including offerings suitable for foliar, seed, or soil treatments across diverse crop types. The shift toward digital procurement channels and direct-to-grower models has introduced new competitive dynamics for traditional distributors and retailers. In parallel, partnerships between ingredient producers and formulators have accelerated, enabling faster route-to-market for novel extracts and concentrated solutions. These alliances often center on co-development, intellectual property sharing, and aligned go-to-market investments.

As the industry professionalizes, sustainability narratives are being reframed to emphasize quantifiable agronomic benefits rather than generic environmental claims. That reframing supports adoption in crops where return on investment is scrutinized closely and expands the relevance of biostimulants beyond premium horticulture into broader field crop applications. Taken together, these transformative shifts signal a maturing category where scientific rigor, commercial execution, and supply chain resilience determine competitive advantage.

The layered operational and commercial consequences of recent tariff measures on sourcing, formulation strategy, and supply chain resilience in the United States

Recent tariff actions implemented in the United States have introduced a layer of complexity across the non-microbial biostimulant supply chain, affecting feedstock sourcing, formulation costs, and logistics planning. Because many active ingredients and raw materials originate from diverse global suppliers, particularly in regions with specialized extraction capabilities, changes in import duties have forced formulators to reassess procurement strategies. This reassessment has included nearshoring certain inputs, qualifying alternate suppliers with overlapping chemistries, and increasing buffer inventories to hedge against volatility.

The cumulative effect has been more than a simple price adjustment; it has reshaped commercial relationships and product development timelines. Suppliers with vertically integrated supply chains or diversified sourcing have been better positioned to absorb tariff-related cost pressures while maintaining stable customer offerings. Conversely, smaller formulators and niche suppliers that relied on single-source imports have faced longer lead times and higher landed costs, prompting some to reevaluate their product portfolios or to accelerate reformulation efforts that use tariff-exempt or domestically sourced alternatives.

Operationally, logistics and trade compliance teams have taken on greater prominence within commercial functions, collaborating more closely with product managers to assess duty classification, origin documentation, and cost pass-through strategies. In many cases, companies have adopted a segmented approach that prioritizes continuity for high-value, performance-differentiated formulations while seeking cost-effective substitutes for more commoditized blends. From a go-to-market standpoint, channel partners are negotiating revised pricing models and promotional frameworks to reflect altered cost structures, and procurement teams are emphasizing multi-source qualification and long-lead contracting to mitigate future shocks. These adjustments illustrate how trade policy reverberates through product design, commercial negotiation, and operational planning, reinforcing the need for resilient sourcing strategies and flexible formulation roadmaps.

Precision segmentation insights revealing how product types, sources, crop demands, forms, applications, and channels determine technical priorities and commercial success

Segmentation analysis reveals how product architecture, source characteristics, crop end-use, physical form, application modality, end-user profile, and channel dynamics collectively shape product development priorities and commercial strategies. When considering product type, portfolios that include amino acids and peptides, humic substances, plant extracts, protein hydrolysates, and seaweed extracts must balance efficacy, consistency, and cost; within amino acids and peptides, chelated amino solutions and peptides provide distinct functional profiles, while fulvic acid and potassium humate represent differentiated pathways within humic substances, and botanical extracts and plant hormone extracts offer varying modes of action within plant extracts. Source selection between inorganic and organic options informs formulation choices, regulatory pathways, and grower preferences, and influences how products are positioned across crops.

Crop type segmentation further drives technical and commercial decisions, with formulations tailored to the physiological demands of field crops, fruits and vegetables, ornamentals, and turf grass. Field crops such as cereals, oilseeds, and pulses require scalability and compatibility with mechanized application, whereas fruits and vegetables like berries, lettuce, and tomatoes often demand targeted solutions that support yield consistency and post-harvest quality. Ornamentals, including hibiscus, orchids, roses, and tulips, prioritize aesthetic attributes and precise nutrient modulation, and turf grass types such as bermudagrass and kentucky bluegrass focus on stress tolerance and rapid recovery. Form considerations-liquid versus powder-affect shelf life, ease of handling, and application flexibility; liquids that are formulated as concentrate or ready-to-use solutions offer different value propositions compared to powders available as granular or soluble powder formats.

Application method segmentation-foliar spray, seed treatment, and soil treatment-shapes both formulation science and go-to-market mechanics. Foliar products that accommodate drone application or manual application must harmonize droplet stability and coverage, while seed treatments that utilize coating or priming technologies intersect with seed supply chains and treatment infrastructure. Soil treatments delivered via drip irrigation or fertigation require solubility and compatibility with irrigation systems. End-user differentiation between commercial users and individual users affects packaging sizes, technical support expectations, and distribution preferences. Distribution channel segmentation between offline and online channels, with online trade split between company websites and third-party marketplaces, drives how brands allocate marketing investments, control product narratives, and manage pricing consistency across touchpoints. By integrating these segmentation dimensions, companies can prioritize formulation investments, channel strategies, and customer support models that align with the specific needs of target cohorts.

Regional adoption patterns and operational considerations that require tailored product, regulatory, and channel strategies across the Americas, EMEA, and Asia-Pacific

Regional differentiation in adoption drivers and commercial dynamics underscores the need for tailored strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, growers often prioritize solutions that integrate seamlessly with large-scale mechanized operations and that offer demonstrable improvements in nutrient efficiency and stress mitigation; distribution networks are diversified and include strong wholesale and retail channels, and digital purchasing is accelerating adoption among commercial agribusinesses. This region also reflects a pragmatic mix of early uptake for high-value horticultural applications and scaling interest in broadacre crops where return on agronomic performance is clear.

In Europe, Middle East & Africa, regulatory scrutiny around inputs and environmental outcomes has prompted suppliers to emphasize compliance documentation and transparent ingredient sourcing. Grower expectations in this region often center on sustainable credentials and traceability, which shapes labeling and communication strategies. Meanwhile, localized climatic stressors and crop mixes necessitate region-specific formulations and application recommendations, and partnerships with local agronomy providers are essential for adoption.

Asia-Pacific exhibits a complex mosaic of smallholder-dominated landscapes and rapidly modernizing commercial agriculture. In many countries, intensive cropping systems and limited arable land encourage adoption of products that enhance resource efficiency and resilience. Distribution varies considerably, with some markets driven by modern trade and e-commerce while others rely on traditional agro-dealers. Supply chain considerations, including proximity to extraction and processing facilities for seaweed and plant extracts, influence cost structures and product availability. Across regions, companies that adapt technical claims, packaging sizes, and channel engagement models to local agronomic realities and purchasing behaviors are best positioned to convert interest into sustained use.

Strategic playbook of industry leaders emphasizing evidence, supply chain resilience, digital enablement, and partnership-driven commercial scale

Leading companies in the non-microbial biostimulant space are converging on several strategic priorities that distinguish high-performing organizations from the broader competitive set. Foremost is an investment in robust evidence generation, where integrated trial networks and independent validation studies are used to substantiate physiological effects under representative agronomic conditions. Firms pairing these scientific investments with clear agronomic guidance and educational programs strengthen distributor and grower confidence in product performance.

Supply chain differentiation is another hallmark of successful players. Companies that secure diversified feedstock pools, maintain flexible formulation platforms, and invest in formulation technologies that improve stability and ease of application create commercial advantages. These capabilities are often complemented by closer integration with distribution partners, where shared demand planning and co-marketing initiatives align incentives and reduce churn. Additionally, digital tools that deliver precision dosing recommendations, application timing alerts, and performance tracking have become key differentiators, supporting repeat purchase and enabling outcome-based conversations with customers.

On the commercial front, leading organizations deploy tiered portfolio strategies that balance high-margin, performance-differentiated products with broader-use, price-sensitive offerings. This approach allows for targeted investment in innovation while maintaining broad market reach. Finally, companies that pursue strategic partnerships-whether through co-development agreements with raw-material specialists or distribution alliances with regional channel leaders-amplify scale and accelerate market penetration without proportionate increases in fixed costs. These combined capabilities shape an organizational playbook that couples science, supply resilience, and commercial execution.

Actionable steps companies should implement now to fortify supply resilience, validate performance across geographies, and optimize portfolio and channel economics

Industry leaders can take immediate steps to strengthen market position by aligning technical investments with commercial execution and operational resilience. Prioritize rigorous field validation programs that span geographies and crop types to create a robust evidence base that supports differentiated claims and informs agronomic guidance. Parallel to validation, reevaluate supply chains with an emphasis on supplier diversification, quality assurance controls, and contractual terms that reduce exposure to trade policy volatility. This dual focus will protect product integrity while enabling adaptive sourcing strategies.

Commercially, refine portfolio architecture to explicitly link product tiers to customer segments and channel economics. Invest in packaging and formulation formats that match end-user preferences, from concentrated liquids for large-scale commercial operations to convenient ready-to-use options for individual users. Enhance digital engagement by deploying decision-support tools and performance dashboards that increase perceived value and foster loyalty. Operationally, strengthen cross-functional collaboration among R&D, procurement, and sales teams to accelerate reformulation cycles when feedstock constraints emerge and to streamline product introductions.

Finally, build strategic partnerships that extend capabilities without commensurate fixed-cost increases. Co-development agreements with extraction specialists, joint trials with leading growers, and distribution alignments in key regions will expand reach and credibility. Implementing these recommendations will help companies translate scientific promise into durable commercial advantage while mitigating external risks.

An integrated mixed-methods research approach combining primary trials, stakeholder interviews, technical dossier review, and supply chain verification to generate actionable insights

This study synthesizes primary agronomic trial data, supplier and distributor interviews, product technical dossiers, and secondary literature focused on formulation science and trade dynamics. Primary engagement included structured discussions with agronomists, formulation chemists, procurement leads, and channel partners to capture operational realities and strategic responses to recent policy shifts. Trial evaluations emphasized replicated trials under representative environmental conditions and included both qualitative agronomic observations and quantitative physiological markers when available.

Secondary sources were reviewed to contextualize ingredient sourcing trends, regulatory developments, and channel evolution. Trade and logistics inputs were corroborated through discussions with supply chain specialists and customs compliance professionals to ensure that tariff implications were reflected in operational decision-making. Throughout the research process, findings were triangulated across data streams to ensure consistency and to identify gaps requiring further validation. The methodology deliberately emphasized actionable insights and cross-functional relevance to support commercial decision-makers and technical leads alike.

Synthesis of strategic imperatives that tie scientific validation, sourcing agility, and tailored commercial models to durable competitive outcomes

In closing, the non-microbial biostimulant domain stands at the intersection of technical innovation and commercial maturation. As evidence-based validation becomes a market entry requirement, companies that invest in rigorous trials, resilient sourcing, and channel-specific value propositions will secure competitive advantage. Trade policy developments and regional structural differences necessitate adaptive strategies that integrate procurement agility with targeted product design.

The cumulative themes of scientific rigor, supply chain resilience, and differentiated commercial execution point to a pragmatic road map: validate claims in the contexts that matter to end users, structure portfolios to match operational realities across crop types and regions, and partner strategically to scale without losing technical focus. Executives and functional leaders that operationalize these priorities will be better positioned to convert biostimulant potential into tangible agronomic and commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Development of nano-encapsulated humic and fulvic acid formulations for controlled release in crop trials
  • 5.2. Rising use of seaweed extract combinations with micronutrients for enhanced drought tolerance in cereals
  • 5.3. Adoption of drone and UAV based foliar application systems for precise non-microbial biostimulant delivery
  • 5.4. Regulatory harmonization efforts between US and EU to streamline registration of plant-derived biostimulants
  • 5.5. Integration of non-microbial biostimulants into seed coatings to boost early root development and uniform emergence
  • 5.6. Employing high throughput phenotyping to quantify efficacy of biostimulant treatments under abiotic stress conditions

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Non-microbial Biostimulants Market, by Product Type

  • 8.1. Introduction
  • 8.2. Amino Acids And Peptides
    • 8.2.1. Chelated Amino Solutions
    • 8.2.2. Peptides
  • 8.3. Humic Substances
    • 8.3.1. Fulvic Acid
    • 8.3.2. Potassium Humate
  • 8.4. Plant Extracts
    • 8.4.1. Botanical Extracts
    • 8.4.2. Plant Hormone Extracts
  • 8.5. Protein Hydrolysates
  • 8.6. Seaweed Extracts

9. Non-microbial Biostimulants Market, by Source

  • 9.1. Introduction
  • 9.2. Inorganic
  • 9.3. Organic

10. Non-microbial Biostimulants Market, by Crop Type

  • 10.1. Introduction
  • 10.2. Field Crops
    • 10.2.1. Cereals
    • 10.2.2. Oilseeds
    • 10.2.3. Pulses
  • 10.3. Fruits & Vegetables
    • 10.3.1. Berries
    • 10.3.2. Lettuce
    • 10.3.3. Tomatoes
  • 10.4. Ornamentals
    • 10.4.1. Hibiscus
    • 10.4.2. Orchids
    • 10.4.3. Roses
    • 10.4.4. Tulips
  • 10.5. Turf Grass
    • 10.5.1. Bermudagrass
    • 10.5.2. Kentucky Bluegrass

11. Non-microbial Biostimulants Market, by Form

  • 11.1. Introduction
  • 11.2. Liquid
    • 11.2.1. Concentrate
    • 11.2.2. Ready To Use
  • 11.3. Powder
    • 11.3.1. Granular
    • 11.3.2. Soluble Powder

12. Non-microbial Biostimulants Market, by Application Method

  • 12.1. Introduction
  • 12.2. Foliar Spray
    • 12.2.1. Drone Application
    • 12.2.2. Manual Application
  • 12.3. Seed Treatment
    • 12.3.1. Coating
    • 12.3.2. Priming
  • 12.4. Soil Treatment
    • 12.4.1. Drip Irrigation
    • 12.4.2. Fertigation

13. Non-microbial Biostimulants Market, by End User

  • 13.1. Introduction
  • 13.2. Commercial User
  • 13.3. Individual User

14. Non-microbial Biostimulants Market, by Distribution Channel

  • 14.1. Introduction
  • 14.2. Offline
  • 14.3. Online
    • 14.3.1. Company Websites
    • 14.3.2. Third Party Marketplaces

15. Americas Non-microbial Biostimulants Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Non-microbial Biostimulants Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Non-microbial Biostimulants Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. BASF SE
    • 18.3.2. Syngenta AG
    • 18.3.3. Agricen
    • 18.3.4. Agrinos Inc.
    • 18.3.5. AgroLiquid
    • 18.3.6. Arysta LifeScience Corporation
    • 18.3.7. Bio Huma Netics, Inc.
    • 18.3.8. Bioiberica S.A.
    • 18.3.9. Biolchim S.p.A.
    • 18.3.10. Biostadt India Limited
    • 18.3.11. Corteva, Inc.
    • 18.3.12. FMC Corporation
    • 18.3.13. Haifa Group
    • 18.3.14. Helena Agri-Enterprises LLC
    • 18.3.15. Hello Nature Worldwide
    • 18.3.16. Isagro S.p.A.
    • 18.3.17. Koppert Biological Systems
    • 18.3.18. L.Gobbi Srl
    • 18.3.19. Lallemand Inc.
    • 18.3.20. Novozymes A/S
    • 18.3.21. Rovensa Next
    • 18.3.22. Seipasa
    • 18.3.23. UPL Limited

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. NON-MICROBIAL BIOSTIMULANTS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. NON-MICROBIAL BIOSTIMULANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NON-MICROBIAL BIOSTIMULANTS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHAI
  • FIGURE 30. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHSTATISTICS
  • FIGURE 31. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHCONTACTS
  • FIGURE 32. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NON-MICROBIAL BIOSTIMULANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CHELATED AMINO SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CHELATED AMINO SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POTASSIUM HUMATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POTASSIUM HUMATE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BOTANICAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BOTANICAL EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT HORMONE EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT HORMONE EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INORGANIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORGANIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CEREALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PULSES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERRIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERRIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LETTUCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LETTUCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TOMATOES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TOMATOES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HIBISCUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HIBISCUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORCHIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORCHIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ROSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ROSES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TULIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TULIPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERMUDAGRASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERMUDAGRASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY KENTUCKY BLUEGRASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY KENTUCKY BLUEGRASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY READY TO USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY READY TO USE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY GRANULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY GRANULAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOLUBLE POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOLUBLE POWDER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRONE APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRONE APPLICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY MANUAL APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY MANUAL APPLICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COATING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRIMING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRIMING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FERTIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FERTIGATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMMERCIAL USER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMMERCIAL USER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INDIVIDUAL USER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INDIVIDUAL USER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 145. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 147. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 173. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 175. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 177. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 179. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 181. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 183. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 185. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 187. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 189. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 233. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 237. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 239. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 241. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 243. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 247. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 248. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 249. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 250. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 251. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 253. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 254. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 255. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 256. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 257. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 258. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 259. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 260. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 261. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 262. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 263. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 264. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 265. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 266. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 267. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 269. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 271. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 272. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 273. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 277. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 278. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 279. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 280. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 281. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 282. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 283. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 286. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 287. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 288. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 289. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 290. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 291. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 292. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 293. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 295. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 297. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 298. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 299. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 301. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 303. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 304. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 305. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 307. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 309. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 311. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 312. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 313. BRAZIL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. BRAZIL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 315. BRAZIL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZI